Banner Beijersbergen

Roderick Beijersbergen

Signaling networks in cancer

Cancer is a complex, heterogeneous disease, characterized by deregulation of signaling networks in the cell. Components of these deregulated networks are potential targets for therapy. However, it remains a major challenge to identify and select the right targets in individual patients and inhibition of these targets is often associated with short-lived responses.

Large-scale, genome-wide functional genomic screening allows for the unbiased identification of cancer-specific targets and the understanding of resistance, leading to the development of novel (combination) strategies for the treatment of cancer.


This site uses cookies

This website uses cookies to ensure you get the best experience on our website.